Controlling use of antimicrobials in a community teaching hospital.
OBJECTIVE
To test the hypothesis that antibiotic use could be controlled or improved in a community teaching hospital, with improvement defined as reductions in overall use, overall cost, and antimicrobial resistance.


METHODS
Interventional study with historical comparison.


METHODS
A not-for-profit, 900-bed community general hospital with residents in medicine, surgery, obstetrics-gynecology, and psychiatry.


METHODS
Physicians who requested any of the targeted antibiotics.


METHODS
Three categories of inpatient antibiotic orders were monitored beginning in April 2001: conversion from intravenous to oral administration for selected highly bioavailable antimicrobials, cessation of perioperative prophylaxis within 24 hours for patients undergoing clean and clean-contaminated surgery, and consultation with an infectious diseases physician before continuing administration of selected drugs beyond 48 hours. Data were analyzed after the first 33 months. Patient outcomes were reviewed during the hospital stay and at readmission if it occurred within 30 days after discharge.


RESULTS
From April 2001 through December 2003, a total of 1426 requests for antimicrobial therapy met criteria for intervention. Overall physician compliance with the program was 76%, ranging from 57% for perioperative prophylaxis to 92% for intravenous to oral conversion. Antimicrobial costs per patient-day decreased by 31%, from 13.67 US dollars in 2000 (before program implementation) to 9.41 US dollars in 2003. Total savings in acquisition costs were 1,841,203 US dollars for the 3-year period. Resistance to numerous drugs among Klebsiella pneumoniae isolates was also significantly reduced.


CONCLUSIONS
A program to improve the use of antibiotics in a community hospital was successful in reducing overall use, overall cost, and antimicrobial resistance.
Philmon
Carla
C
Department of Infectious Diseases, Pharmacy, and Laboratory, Presbyterian Hospital of Dallas, TX 75231, USA. carlaphilmon@texashealth.org
Smith
Terri
T
Williamson
Sharon
S
Goodman
Edward
E
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000191:economics; D017046:Cost Savings; D003625:Data Collection / Q000379:methods; D004351:Drug Resistance; D004363:Drug Utilization / Q000191:economics / Q000706:statistics & numerical data*; D006764:Hospitals, Community; D006784:Hospitals, Teaching; D006801:Humans; D008505:Medical Staff, Hospital; D010818:Practice Patterns, Physicians'; D013781:Texas
D000900:Anti-Bacterial Agents